GetTopicDetailResponse(id=1c9f4820831, topicName=巨球蛋白血癥, introduction=巨球蛋白血癥, content=null, image=null, comments=1, allHits=1473, url=https://h5.medsci.cn/topic?id=48208, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=25717, tagList=[TagDto(tagId=25717, tagName=巨球蛋白血癥)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2248881, encodeId=b585224888143, content=<a href='/topic/show?id=648e915e602' target=_blank style='color:#2F92EE;'>#診斷#</a> <a href='/topic/show?id=1c9f4820831' target=_blank style='color:#2F92EE;'>#巨球蛋白血癥#</a>, objectTitle=反復牙齦出血，頭暈乏力，平素身體健康的他竟被這種罕見病困擾, objectType=article, longId=860230, objectId=eb898602301e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240521/1716270876626_5579292.png, objectUrl=/article/show_article.do?id=eb898602301e, replyNumber=0, likeNumber=40, createdTime=2025-01-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=eb898602301e, moduleTitle=反復牙齦出血，頭暈乏力，平素身體健康的他竟被這種罕見病困擾, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=eb898602301e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1220367, encodeId=b3a8122036e77, content=<a href='/topic/show?id=820e3228e1b' target=_blank style='color:#2F92EE;'>#利妥昔單抗#</a>與<a href='/topic/show?id=1c9f4820831' target=_blank style='color:#2F92EE;'>#巨球蛋白血癥#</a>, objectTitle=J Clin Oncol：伊布替尼（Ibrutinib）+利妥昔單抗對比安慰劑+ 利妥昔單抗治療Waldenstrm巨球蛋白血癥的療效:來自隨機III期iNNOVATE研究最終分析結果, objectType=article, longId=218141, objectId=54be2181415e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021105/1633411938974_1611618.jpg, objectUrl=/article/show_article.do?id=54be2181415e, replyNumber=0, likeNumber=139, createdTime=2022-05-17, rootId=0, userName=賽華佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54be2181415e, moduleTitle=J Clin Oncol：伊布替尼（Ibrutinib）+利妥昔單抗對比安慰劑+ 利妥昔單抗治療Waldenstrm巨球蛋白血癥的療效:來自隨機III期iNNOVATE研究最終分析結果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=54be2181415e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
